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Cardiac Catheterization: Indications in Coronary
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GEORGE W . VETROVEC, M. D.
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Mitra! Valve Disease: When is Surgery Needed?
ZUBAIR UL HASSAN, M .D.
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JOHN C . QUINN, M.D.

ure- The McGuire Lecture
DEAN T . MASON, M .D.

Echocardiography
KIRAN B . SAGAR, M .D.

Surgery for Coronary Disease: Indications and
Resu lts
RICHARD R. LOWER, M.D.

Hypertension: New Drugs
ALBERT J. WASSERMAN, M. D.

Medical Management of Angina: Methods and
Results
ANDREA HASTILLO, M. D.

Hypertension: Management of the Difficult Patient
A . JARRELL RAPER, M. D.

INTRODUCTION
With this issue we continue the proceedings of the 50th Annual McGuire Lecture Series on Cardiology in Primary Care. In
our Scripta Medica section we present a paper by Dr. James C. M. Chan on hyperuricemic nephropathy.
THE EDITORS

Results of Aortocoronary Bypass Surgery
for Angina Pectoris
RICHARD R. LOWER , M.D.
SZABOLCS SZENTPETERY , M.D.
TIMOTHY WOLFGANG , M.D.
V. ERIC KEMP , M.D .
From the Division of Thoracic and Cardiac Surgery, Medical College of Virginia, Health Sciences
Division of Virginia Commonwealth University, Richmond, Virginia

To determine the relative risks and benefits of coronary bypass surgery for angina pectoris, we examined the results in our first consecutive 360 patients operated upon between
May 1970 and December 1975 . The age
range was 27 to 75 years; there were 309
males and 51 females . The patients were classified clinically as having stable angina in 11 9
cases (33%), unstable angina in 205 cases
(5 7%) and preinfarction angina in 36 cases
(1 0%). Unstable angina was defined as a definite recent increase in severity or frequency of
chest pain , angina at rest or nocturnal angina .
Preinfarction angina was defined as a syndrome
of prolonged angina, poorly controlled by nitrites, occurring at rest with typical ECG changes
of ischemia. Such patients underwent observation in the Coronary Intensive Care Unit followed
by emergency arteriography and surgery, usually within 24 hours.
All patients had preoperative coronary arteriograph y and left ventriculography . Significant
lesions were defined as 50% or more narrowing
of the left main coronary artery and 75% or
greater narrowing of the other vessels . Abnormal left ventricular function was defined as an
ejection fraction of less than 40% and was conThis paper reports the clinical results of a five-year
study of bypass surgery patients at the Medical College of
Virginia.
Corresponde nce and reprint requests to Dr. Richard
Lower, Box 97 , Medical College of Virginia, Richmond , VA
23298.

sidered severe if the ejection fraction was less
than 25% or if a large left ventricular aneurysm
was present. Forty-three patients (1 2%) had left
main-vessel disease , 83 (23%) had single-vessel , 11 5 (32%) double-vessel, and 119 (33%)
triple-vessel disease. One hundred and ninetyfour patients (54%) had abnormal ventricular
function and in 84 (23%) it was considered severe. Eighty-four (23%) patients had single bypass surgery, 135 (38%) patients had double
bypass, and 140 (39%) patients had three or
more grafts. One patient died in the operating
room before bypass could be carried out. (See
below .) Twenty-two patients (6%) had concomitant left ventricular aneurysm resection and
are included in the analysis. Patients with angina pectoris were excluded from surgical therapy only if the left ventricular ejection fraction
was less than 15% in the absence of a large left
ventricular aneurysm or if there were no suitable
vessels for grafting .
The operation (Fig 1) generally involved
the use of the saphenous vein as the bypass
conduit. When the greater saphenous vein was
unavailable or inadequate, alternative choices
included the internal mammary artery, lesser saphenous vein , and in two instances, Gortex synthetic grafts. Operation was carried out under
hemodilution and moderate systemic hypothermia of 28 C to 30 C , using intentional ventricular fibrillation and intermittent aortic occlusion
for periods not exceeding 20 minutes, or alternatively, cardioplegia with cold hyperkalemic
MCV OUARTERLY 15(2):43-46, 1979 /
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Fig 2-Proportion of patients surviving following coronary
graft surgery at the Medical College of Virginia from 1 970
through May 31, 1976.

frequently, an intraventricular thrombus was removed during aneurysm resection_

Fig 1-Technique usually employed for aortocoronary bypass, utilizing saphenous vein to revascularize the distal
right, marginal circumflex, and left anterior descending
branches.

solution for longer periods of arrest. When considered appropriate, coronary artery endarterectomy was carried out in addition to bypass
grafting, most frequently involving the distal
right coronary artery and occasionally the left
anterior descending or circumflex branches .
Aneurysm resection was performed in a standard fashion only when there was a full thickness scar with thinning of the ventricular wall;

TABLE 1
Estimated survival proportions for patients undergoing coronary

bypass surgery at MCV from 1970 through May 31, 1976
Months after
bypass

Alive at

Died

Withdrawn

beginning of

during

alive during

surgery

interval

interval

interval

0-6
6-12
12-18
18-24
24-30
30-36
36·42
42-48
48-54
54-60

360
324
277
233

9
1
1
0

27
46
43
35
47
28
42
24
21
14

198

J

148
117
74
49
28

3
1
1
0
0

Estimated proportion
surviving to end
of interval (cumulative)

*Standard error of the five year survival proportion is 0 .0248 .

0.974
0.971
0.967
0.967
0.950
0.929
0.919
0.905
0.905
0.905*

Results
There were two operative deaths and four
postoperative deaths within the first month for a
total operative mortality of 1. 7%. One operative
death in a 54-year-old female with stable angina and two-vessel disease resulted from an
iatrogenic intraoperative aortic dissection, with
death occurring before extracorporeal circulation could be established. This was the only operative or postoperative death in the group of
patients with stable angina . The second operative death was in the only patient who could
not be weaned from cardiopulmonary bypass.
Postmortem examination of the 62-year-old
male revealed extensive three-vessel disease,
an old anterior wall infarction, and a posterior
wall infarction (unsuspected preoperatively) estimated to be of two to three days' duration . No
other patient required intraoperative or postoperative intra-aortic balloon assist. The operative mortality in the last four years of the study
was 0. 7% . There were four early postoperative
deaths within one month: one from acute myocardial infarction occurring in a non~
revascularized area one week after operation,
one from acute renal failure in a patient with
chronic renal disease, one from an unsuspected, ruptured abdominal aneurysm in an
obese patient, and one from a dissecting aneurysm in a patient with severe myxedema.
During this same period of study, 33 patients had operations for valve disease and concomitant coronary bypass grafting with no operative or hospital deaths in this group. However,
these patients were not included in the analysis
of surgery for angina pectoris and are not further considered in this report.
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TABLE 2

Estimated proportionsreporting angina free status following
coronary bypass surgery at MCV from 1970 through May 31, 1975
Years
after
graft

Angina free at
beginning of
interval

Symptoms
returned during
interval

Withdrawn
angina free during
interval

Cumulative proportion
angina free at end of
interval

264
187
119
75
54

78
22
6
1
1

0
46
37
43
20

0.706
0.611
0.575
0.564
0.552*

0-1
1-2
2-3
3-4
4-5

*Standard error for proportion angina free five years after surgery is 0.035.

Within the series of patients operated
upon for angina pectoris, the perioperative infarction rate was studied in 1 00 consecutive patien ts with serial ECGs, vectorcardiography,
and serum enzymes . A new perioperative infarction, one of which was fatal, was diagnosed
in four patients.
There were 1 3 late postoperative deaths
(3 .4 % ) occurring two months to four years after
operation; all were in patients who were classified preoperatively as unstable or having
preinfarction angina. In each case there was abnormal ventricular function demonstrated preoperatively and in six patients it was considered
severe. Two patients had aneurysmectomy in
addition to bypass . Twelve of the 13 patients
had documented myocardial infarction preoperatively. Ten of the patients had three-vessel
disease and three of the patients two-vessel disease. Three of the deaths were non-cardiac in
origin; one of disseminated malignancy and two
from stroke. There have been no operative or
postoperative deaths in patients with single-vessel disease. No late deaths have occurred during the period of this study in patients with a

preoperative classification of stable angina pectoris . There were no operative or early postoperative deaths in patients with left main-vessel disease, and two late postoperative deaths
have occurred in this group. Statistical analysis
of all patients by life table methods (Table 1 and
Fig 2), including the operative deaths, revealed
a five-year expected survival rate of approximately 91 % .
To evaluate the degree of palliation and its
duration , follow-up evaluation was carried out in
all surviving patients who had survived more
than one year after operation at the time of the
study. Evaluation consisted of personal examination, mail questionnaire, or telephone interview, with 1 00% follow-up. On the basis of the
interviews, patients were classified as 1) asymptomatic, 2) impro\;'ed, though with some angina,
or 3) unimproved. An attempt was made to define when in the postoperative course angina
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§
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TABLE 3

0.20
0.10

beginning of

interval

improved during

interval

Cumulative proportion
improved at end
of interval

0-1

265

12

0

0.955

1·2
2-3

253

2

75

0.946

176

71

0.939

3-4
4.5

104

60

44

34

0.939
0.939*

* Standard

Angina Free

~ 040
0.30

Years
after
graft
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~Proportion

a.

coronary bypass surgery at MCV from 1970 through May 31, 197'>
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Proportion Improved

a.
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Fig 3-Proportion of patients reporting improved status and
proportion reporting angina-free status following coronary
vein graft surgery from 1970 through May 31, 1976 at the
Medical College of Virginia .
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had reappeared or when therapeutic failure had
occurred. Similar life table analysis of the duration of palliation (Tables 2 and 3, Fig 3) revealed that at five years 55% of the patients
were anticipated to be pain-free and 93%
asymptomatic or improved , with 7% either unimproved or worse .
Conclusions
These results appear to show that aortocoronary bypass grafting for angina pectoris
can be carried out with relative safety and effectiveness in the majority of properly selected patients . The risk appears particularly low in patients with single-vessel disease, those with
stable angina, and those with good left ventricu-

lar function . The operative risk also appears appropriately low for all patients with left ventricular ejection fraction above 1 5% so long as
suitable graftable vessels are present even if
concomitant ventricular aneurysm resection is
required. Determination of the ultimate value of
aortocoronary bypass grafting in terms of prolongation of life and duration of palliation will require several more years of analysis in view of
the generally progressive nature of the disease
both in the native circulation and in the bypass
grafts. However, the analysis of this group of
patients from one to five years after operation
strongly suggests that operation has provided
improved longevity as well as effective palliation .
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Surgical Treatment of Mitral Valve Disease
ZU BAIR UL HASSAN, M.D.
Assistant Professor of Medicine, and Director, Cardiac Catheterization Laboratory, McGuire Veterans
Administration Hospital, Richmond, Virginia

This paper discusses the indications for
su rgery in mitral valve disease by comparing the
natural history of the disease, as it can best be
determined from the literature, with the results
of various surgical procedures. It may be stated
at the outset, however, that there are no controlled studies comparing medical and surgical
treatment nor are they likely to be carried out in
th e near future.

Mitral Stenosis
1. Detection. While the auscultatory findings of mitral stenosis are characteristic , many
patients go undetected by routine clinical examination; it is, therefore, important to be aware of
the special syndromes with which they may
present (Table 1).
Mitra! stenosis is much more common in
women and should be looked for particularly in
those who are young or middle-aged . The condition is predominantly a sequel to rheumatic
heart disease which is prevalent among large
families from lower socioeconomic groups. The
availability of M-mode echocardiography in recent years has been of great help in the detection of mitral stenosis, since this procedure has
nearly 1 00% sensitivity and the specificity is almost as good . With the two-dimensional echocardiogram the degree of stenosis can be measured with great precision by mapping out the
valve area . Echocardiography has thus eliminated the need for cardiac catheterization either
for th e detection or quantification of mitral stenosis, and cardiac catheterization is now emCorrespondence and reprint requests to Dr . Zubair ul
Hassan, McGuire VA Hospital , 1201 Broad Rock Road ,
Richmond, VA 23249.

ployed only preoperatively for the detection and
assessment of associated lesions.
2 . Natural history. Bland and .Jones in
their classical 20-year study of 1 ,000 patients
with acute rheumatic fever showed the extreme
variability in the rate of progression of mitral stenosis in different patients. 1 Some patients developed mitral stenosis within 5 years after the first
attack of rheumatic fever while others were relatively well even 50 years later; however, a composite average can be deduced from this and
other studies. In the preantibiotic era, mitral stenosis was clinically detectable approximately
1 0 years after the onset of acute rheumatic fever, symptoms were minimal in the next 10
years unless pregnancy or complications occurred (for example, endocarditis or atrial fibrillation}, and in the next 20 years symptoms increased progressively with development of
pulmonary hypertension , heart failure , and systemic embolism, leading to death , approximately 40 years after the onset of rheumatic fever, at an average age of 48 (Fig 1). 1 - 3
It is my impression that mitral stenosis
today shows a slower rate of progression in the
industrialized countries, mainly because the use
of antibiotics has considerably improved the
rate of recurrence of rheumatic fever and the
treatment of endocarditis.
One of the most useful studies of the natural history of mitral stenosis is by Olesen and
Baden who classified their patients according to
the New York Heart Association (NYHA) classification and compared the non-surgical groups
seen during the years 1933-1 950 with the initial 1 65 consecutive patients operated on during the years 1950-1955 (Fig 2).4 Most studies
of surgical treatment of mitral stenosis have
MCV QUARTERLY 15(2):47-54 , 1979
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TABLE 1
Some Presenting Syndromes in Mitral Stenosis
EXERTIONAL DYSPNEA OR PULMONARY
EDEMA WITHOUT GENERALIZED CARDIOMEGALY
A TRIAL FIBRILLATION
SYSTEMIC EMBOLISM
(STROKE, MYOCARDIAL INFARCTION, HEMATURIA,
ETC.)
HEMOPTYSIS WITHOUT PULMONARY INFECTION
RESTRICTIVE AND OBSTRUCTIVE LUNG DISEASE
WITHOUT SMOKING HISTORY

used Olesen and Baden's non-surgical patients
for comparison . In NYHA Class II patients with
normal sinus rhythm the ten-year survival was
80%. At the other extreme over 50% of Class
IV patients were dead within five years and all
were dead within eight years.

3. Choice of operations and results . The
possibility of correcting the mechanical problem
of mitral stenosis surgically was first discussed
around the turn of the 20th century. The first attempts at surgical correction were made in the
1 920s, but mitral valvotomy has come to be
recognized as a generally acceptable method of
treatment only since 1948. Today several different surgical procedures are available for the
repair of mitral valve disease, some of the more
common being listed in Table 2.
The operative and postoperative morbidity
and mortality rates are very low for mitral commissurotomy but considerable when mitral valve
replacement with a prosthesis is necessary . It
is important, therefore, to determine preoperatively whether the patient with mitral stenosis will require commissurotomy or valve replacement. Table 3 gives some of the signs that
determine this decision. Successful mitral com-
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'.J
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Fig 1-Natural progression of mitral stenosis. Clinical course, pathology and hemodynamic changes are correlated. Valve area
is indicated below each diagram of valve. CO = cardiac output; Exer = exercise; LA = left atrial pressure; N = normal; PA =
pulmonary arterial pressure; i = decreased; j = increased.
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Fig 2---Mitral Stenosis: Survival curves of surgery and medically treated patients. A. Normal sinus rhythm (NSR), NYHA Class II,
B. NSR, NYHA Class Ill; C. Atrial fibrillation and NYHA Class II or Ill; D. NYHA Class IV. Vertical bars give 2 standard errors
above and below each point.

missurotomy is not possible if significant regurgitation accompanies stenosis or if the valve is
heavily scarred, markedly deformed, or calcified and immobile. Attempts at valvotomy in calcified valves result in fracture of the valve with
resu ltant insufficiency rather than cleavage of
the commissures. Lack of valve mobility is evident clinically by the absence of an opening
snap and the presence of a muffled first heart
sound; calcification can be detected by fluoroscopy and echocardiography. Repeated commissurotomies also cause extensive scarring
and deformity which necessitate valve replacement.
Olesen and Baden showed that 'closed'

TABLE 2
Common Operations Available for Mitral Valve
Disease

• COMMISSUROTOMY
CLOSED
OPEN
• VALVE REPAIR
ANNULOPLASTY
VAL VULOPLASTY
CARPENTIER RING
• VALVE REPLACEMENT
CAGE AND BALL VALVE
TILTING DISC VALVE
PORCINE TISSUE VALVE

HASSAN: SURGERY FOR MITRAL VALVE DISEASE/
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TABLE 3
Signs Indicating Probable Need for Valve
Replacement in Mitral Stenosis

•
•
•
•

INTENSITY OF S 1 OR OPENING SNAP REDUCED
SIGNIFICANT MITRAL INSUFFICIENCY
DENSE CALCIFICATION OF MITRAL VALVE
PRIOR MITRAL SURGERY

mitral commissurotomy (that is, commissurotomy without cardiopulmonary bypass or
'open'-heart surgery) improved survival in all but
minimally symptomatic patients in normal sinus
rhythm .4 Long-term survival was adversely affected by the presence of preoperative pulmonary hypertension or postoperative mitral insufficiency. Ellis, Harken and Black reported
essentially similar results in a much larger series
of 1 ,000 surgical cases. 5
In the United States, most institutions use
open mitral commissurotomy (that is, with cardiopulmonary bypass) as the procedure of
choice for mitral stenosis. The results of open
commissurotomy are probably superior to the
closed operation , although it is a more expensive procedure. Improvements in surgical
technique have markedly reduced the incidence
of systemic embolization and mitral insufficiency, which were the principal dangers of
mitral commissurotomy in earlier days. The
mortality from mitral commissurotomy today is
less than 1 % when the operation is done at an
optimal time and most survivors experience improvement in their symptoms.6
When mitral stenosis can be treated with
commissurotomy, the operation should be recommended as soon as symptoms interfere with
the normal enjoyment of life or at the earliest
signs of complications. In a substantial minority
of patients, the valve restenoses after several
years with recurrence of symptoms. Additional
surgery should be considered in these patients.
The other types of mitral valve surgery will
be discussed with the treatment of mitral insufficiency.

Mitral Regurgitation
The causes of mitral regurgitation are numerous; however, it is usually caused by congenital heart defects in young children, rheumatic heart disease or mitral valve prolapse in
young adults, and coronary artery disease in
older patients. The systolic apical murmur radiating into the axilla is usually easy to detect and

50
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is almost diagnostic of mitral regurgitation, although occasional patients with aortic stenosis
have their murmur referred to the mitral area.
Rupture of chordae tendineae to the posterior
mitral leaflet may produce a murmur loudest at
the sternum, simulating aortic stenosis. After
mitral valve replacement, significant mitral regurgitation may occur silently but should be suspected if left ventricular failure or hemolytic
anemia develops unexpectedly.
Detailed studies of the natural history of
mitral regurgitation according to severity of the
lesion or staging by symptoms are not available.
Some impressions can be drawn from the prospective study of rheumatic fever by Bland and
Jones. 1 The prognosis of asymptomatic, mild,
chronic mitral regurgitation without cardiomegaly is no different from that of the normal population ; however, when significant symptoms are
present with moderate-to-marked cardiomegaly, life expectancy is considerably shortened .
In Rapaport's experience approximately 20% of
the patients with mitral regurgitation were dead
within five years and 40% within ten years after
their initial diagnosis.3
Another consideration in mitral regurgitation regarding prognosis is the cause of the lesion . Most patients with mitral valve prolapse
(click- murmur, Barlow syndrome) have a
nonprogressive lesion . Mitra! regurgitation secondary to chronic left ventricular failure and dilatation (for example, cardiomyopathy, hypertension) usually does not respond well to surgical treatment. In contrast with chronic mitral insufficiency, acute mitral insufficiency is very
poorly tolerated and leads to rapid heart failure.
Acute mitral regurgitation usually results from
rupture of papillary muscles, chordae tendineae
or valve leaflets due to infarction, infection or
trauma, and occasionally spontaneously. In
acute cases more attention should be paid to
the severity of the hemodynamic lesion, as determined by physical signs and cardiac catheterization, than to the symptoms.
The combined lesion of mitral stenosis
and regurgitation is usually due to rheumatic
heart disease and is treated like mitral regurgitation because most patients require mitral valve
replacement.

Mitral Valve Repair
The concept of repairing the valve instead
of replacing it with a prosthesis is extremely at-

tractive, particularly for younger patients. 7 - 9 It
avoids the problems of thromboembolism, infection and hemolysis consequent upon the introduction of a foreign body into the bloodstream . The proponents of valve repair claim
that it is feasible in a majority of patients with mitral regurgitation, but others have largely
avoided it. Several different techniques have
been described. Annuloplasty reduces the size
of the valve orifice by plication of the annulus
fusing the peripheral portions of the mitral commissures . Complete obliteration of mitral insufficiency is frequently not possible by this
technique and postoperative dilatation of the
mitral annulus may necessitate valve replacement at a later date. Valvuloplasty is a spectacularly successful and curative operation for
many cases of ruptured chordae tendineae. The
redundant untethered portion of the posterior
leaflet is obliterated by pleating with sutures.
The Carpentier ring is a slightly irregular biarcuate stainless steel ring wrapped in a teflon
collar for sewing which has been recently introduced as an aid to valvuloplasty. The ring
prevents further dilation of the valve, and the
sewing collar is used to anchor the sutures and

A

B

remold the deformed valves to approximate normal anatomy. Risk of thromboembolism and
endocarditis is not significantly increased with
the use of the Carpentier ring . At present, valve
repair should be strongly considered in younger
patients and in those with mitral insufficiency
secondary to rupture of the posterior leaflet
chordae tendineae. With continuing improvements in technique, valve repair is likely to become possible in a larger proportion of patients.
The risk of valve repair is minimal, and marked
symptomatic improvement occurs after successful surgery, but it is not possible to decide
preoperatively whether repair or valve replacement will be necessary in a specific patient. The
indications for valve repair are therefore the
same as for valve replacement as discussed below.

Mitral Valve Prostheses
Three main types of prostheses are currently in use (Fig 3). Various models of the StarrEdward heart valves are examples of the cageball type of prosthesis. Blood flows turbulently
around the occluding ball in contrast to the laminated flow in the normal valve. Long experience

c

Fig 3 -Three commonly used mitral valve prostheses. A. Starr-Edward Model 6120; B. Bjork-Shiley; C. SGP Hancock Porcine
Model 342.
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with these valves has shown them to be durable
and reliable. The main problem is thromboembolism which is reduced but not eliminated by
anticoagulants. Traumatic hemolysis may occur
in models of the valve with cloth-covered struts.
Another problem is the very loud closing click
with some models. This sound can occasionally
be heard by the unaided ear across the room
from the patient. The incidence of infection of
the prosthesis is probably similar to the other
prosthetic valves.
Tilting disc valves, such as the BjorkShiley, have a more physiological blood flow
and a low profile so that the valve does not occlude the left ventricular cavity. The major advantage of this valve is that the sewing ring is
not disproportionately larger than the internal lumen and these valves are therefore associated
with the lowest transvalvar gradients among all
prosthetic heart valves . However, anticoagulation is needed and the closing click can
be quite noisy. This is the prosthetic valve of
choice in patients with a small mitral valve annulus.
Glutaraldehyde-treated porcine heterografts are becoming increasingly popular because of low thrombogenicity even without anticoagulation. These valves consist of porcine
aortic valve tissue mounted on a man-made
frame. Flow is central, very much as in the normal valve, but the sewing ring is considerably
larger than the internal lumen, and large transvalvar gradients may be present postoperatively, particularly with the smaller-sized
sewing rings. Long-term durability is another
major concern . Nevertheless, this is the prosthesis of choice when anticoagulation is contraindicated.
Characteristics of the three valves discussed above are compared in Table 4.
Results of valve replacement. Comparative studies of different types of valve prostheses are not available at present. It appears,
however, that the operative mortality for the different types of prostheses mentioned above is
roughly comparable, and the risk factors for operative mortality and long-term results are also
similar. The most important risk factors for early
operative mortality are advanced heart failure
and marked cardiomegaly, particularly left atrial
enlargement (Fig 4 ). 6 · 10 The long-term results
are adversely affec!ed in patients with marked
left atrial enlargement or pulmonary hyper-

52 /

HASSAN : SURGERY FOR MITRAL VALVE DISEASE

TABLE 4
Comparison of Three Most Commonly Used Prosthetic
Heart Valves. Pros and Cons Graded from One to
Three Plus. S-E = Starr-Edward; B-S = Bjork-Shiley;
P-H = Porcine Hancock.
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tension. Most survivors of the operation show
symptomatic improvement, but their survival
curve does not parallel that of the general population (Fig 5). Young patients with severe mitral
regurgitation show a remarkable reduction in
cardiac size following successful surgery,
whether valve repair or valve replacement. Mitral valve replacement is recommended in all
patients with significant symptoms, that is,
NYHA Class Ill or IV. It is also indicated in acute
severe mitral regurgitation and significant mitral
regurgitation with progressive cardiomegaly or
pulmonary hypertension, even when symptoms
are less impressive (Table 5). It is advisable not
to wait until advanced stages of heart failure,
cardiac enlargement, or pulmonary vascular
changes occur, but unfortunately patients are
all too frequently in this condition when they first
seek, or are referred for, valve surgery.
In summary, the natural history of mitral
valve disease is discussed and compared with
various surgical procedures. Life expectancy is
considerably shortened when mitral stenosis is
accompanied by significant symptoms or complications. Mitral commissurotomy is a relatively
benign procedure (< 1 % mortality) which improves survival and symptoms in these patients.
Chronic mild mitral regurgitation is tolerated
well, but progressive cardiac dysfunction occurs
when regurgitation is severe, particularly if it develops acutely. Valve repair can be performed
in some cases with a low mortality and very low
postoperative morbidity. Most patients with incompetent valves require valve replacement in
which the average surgical mortality is approxi-

EARLY OPERATIVE MORTALITY
ISOLATED MITRAL VALVE REPLACEMENT
MODEL 6120 STARR- EDWARD PROSTHESIS
MAYO CLINIC 3/66 TO 1/72
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Fig 4-Early operative mortality in isolated mitral valve replacement with Model 6120 Starr-Edward prosthesis, Mayo Clinic 366 to 1-7 2 ; A = mortality according to preoperative NYHA classification ; B = mortality according to preoperative left atrial (LA)
size.
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Fig 5--Late survival and systemic thromboembolism in surgical survivors of isolated Starr-Edwards mitral valve replacement
with model 6120 prosthesis compared to normal life expectancy.
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TABLE 5
Indications for Valve Replacement in Mitral
Regurgitation
NYHA CLASS Ill OR IV
SIGNIFICANT ENLARGEMENT OF LEFT ATRIUM OR
VENTRICLE
PULMONARY HYPERTENSION
ACUTE SEVERE MITRAL REGURGITATION

mately 5% ; thromboembolism is the most serious postoperative problem .
Surgical mortality is markedly increased in
advanced heart disease (NYHA Class IV) and
surgical treatment should therefore be considered in all patients with mitral valve disease before this stage is reached.
Figure 1 is taken in part from Proceedings of the Royal
Society of Medicine (60: 1 009-1 01 5, 1 96 7) and the
American Journal of Cardiology (35:221-227, 1975) by
permission.
Figure 2 is adapted from the Scandinavian Journal of
Thoracic and Cardiovascular Surgery (3:119-124, 1969)
by permission.
Figure 4 adapts data found in Barnhorst et al , American Journal of Cardiology (35 :228-233 , 1975).
Figure 5 is adapted from the American Journal of Cardiology (35 :22 8-233, 1975) by permission .
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Assessment for Surgery for Aortic Valve
Replacement
JOHN QUINN, M.D.
Assistant Professor of Medicine and Cardiology, Department of Medicine, Medical College of Virginia ,
Health Sciences Division of Virginia Commonwealth University, Richmond, Virginia

Surgical management of symptomatic
aortic valve disease has been successful in improving both survival and function. Data reported from the literature suggest an operative
mortality of from 5% to 8%, with a lower risk for
elective replacement, and a 65% to 75% 1 - 3
five-year survival rate as opposed to 50% to
60% 4 in non-surgical patients with symptomatic
aortic valve disease.
Aortic Stenosis
Valve replacement for aortic stenosis is
usually indicated when angina pectoris, exertional syncope or congestive heart failure occur. Previous statistics suggest that with angina,
which is the most common symptom, 50% of
patients are dead within five years and with congestive heart failure , 50% are dead within two
years, 5 usually as a result of sudden death. In
the adult, coronary disease is present in approximately half the cases of aortic stenosis. The
etiology of angina may thus be multifactoral
which makes this the most difficult of the major
symptoms to assess. Obviously the severity of
coronary disease influences subsequent survival; coronary bypass surgery at the time of
valve replacement does not substantially alter
perioperative mortality. At the present time a
congenitally malformed bicuspid valve is the
most common cause of aortic stenosis in the
adult. f-meumatic aortic stenosis is now less

Correspondence and reprint requests to Dr. John
Quinn, Box 36, Medical College of Virginia, Richmond, VA
23298 .

common and occasionally calcific tricuspid stenosis (''aortic stenosis of the elderly'') is seen .
Accurate clinical assessment of the severity of aortic stenosis may be difficult, especially
in the elderly and in the patient with congestive
heart failure. As cardiac output falls, the flow
over the aortic valve diminishes and therefore
the intensity of the murmur decreases. The
usual physical findings with severe aortic stenosis include a narrow pulse pressure primarily
because of decreased systolic blood pressure;
a diminished carotid pulse volume with a slow
rise to peak upstroke; a thrill often palpable in
the second right interspace; and a murmur,
most intense in the aortic area, typically of a
crescendo-decrescendo type which peaks late
in systole. An S4 gallop rhythm secondary to
decreased ventricular compliance is audible . In
the adult, the presence of an ejection click usually occurs only with pliable valves; the second
sound may be diminished and becomes single
as left ventricular ejection time increases. The
electrocardiogram usually shows left ventricular
hypertrophy. In the absence of congestive heart
failure or concomitant multivalve disease, the
chest X-ray reveals a normal heart size. The ascending aorta may be dilated secondary to
post-stenotic dilatation, but the aortic knob is
usually small as opposed to patients with generalized tortuosity of the aorta. Ordinarily the adult
has valvular calcification which is seen better by
fluoroscopy. The greater the calcification, the
more likely the stenosis will be severe ; thus fluoroscopy may provide useful information in selecting patients for catheterization . Single dimensional echocardiography reveals dense
MCV QUARTERLY 15(2):55-57, 1979
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echoes in the aortic root but does not yield information on the severity of the valvular stenosis. The newer two-dimensional studies frequently allow one to determine a cross-sectional
area, and show promise in the future of effectively selecting patients for catheterization by a
non-invasive method when the clinical findings
do not suggest severe stenosis.
Catheterization is the single best method
to assess severity. With normal cardiac output,
a large systolic gradient of greater than 50 to
70 mm Hg is usually seen with symptomatic
stenosis. As cardiac output falls for a given
fixed-valve area, the gradient falls; thus the
valve area calculation is of major importance
when the output is diminished. The usual aortic
valve area is approximately 3 cm 2 ; the calculated valve area determined by hydraulic formula, using the observed gradient and measured cardiac output, should be less than 1 cm 2
with symptomatic aortic stenosis and is less
than 0 . 7 cm 2 with severe aortic stenosis .
The decision regarding replacement in the
asymptomatic patient is not clear. Studies in
children ages 2 to 21 6 with gradients greater
than 80 mm Hg reveal that over a period of time
the group operated upon was functionally better
than the medical group; however, survival data
were similar. These findings may not be similar
in the adult; however, if the gradient is severe or
if progressive electrocardiogram or chest x-ray
changes occur then one might consider surgery.

Aortic Regurgitation
Chronic aortic regurgitation has a more
varied etiology and, to a large extent, progression of disease is dependent on the cause . In
general the murmur is detected years before
symptoms occur, and because progression,
even with a large regurgitant volume, is often
slow, the decision regarding valvular replacement is often more difficult than with aortic stenosis. Years may pass before development of
fatigability and then several years more until
frank congestive heart failure occurs, resulting
in an average survival of approximately two
years after the onset of heart failure.
Acute severe aortic regurgitation secondary to endocarditis, aortic dissection or trauma
usually leads to immediate surgery; thus the decision as to valve replacement is not as difficult
as with chronic aortic regurgitation .
In brief, several features on clinical exami-

56 /

QUINN

AORTIC VALVE REPLACEMENT SURGERY

nation that suggest substantial regurgitation are
widened pulse pressure with a low diastolic
valve, bisferins carotid pulsation, rapidly collapsing peripheral pulses, and a displaced
apical impulse. The absence of a diastolic pressure of less than 70 mm or a widened pulse
pressure with the pulse pressure greater than
50% of the peak systolic in patients without
congestive heart failure usually excludes severe
aortic regurgitation . The rapidly collapsing pulses seen with chronic aortic regurgitation are
also seen in high-output states and are not specific. The typical murmur is a decrescendo diastolic type which lengthens as the regurgitant
fraction increases, that is, the longer the murmur, the more severe the regurgitation. The
other auscultatory sign of significant aortic regurgitation is the presence of an Austin Flint
murmur, that is, a middiastolic apical rumble
which may be produced by turbulence because
of closure of the mitral valve in diastole by the
aortic regurgitant jet, with antegrade flow
through the mitral valve, as 75% of the stroke
volume may return to the left ventricle . A systolic flow murmur is often heard but is not helpful in assessing severity. An S3 gallop rhythm is
common.
The electrocardiogram in severe aortic regurgitation should show left ventricular hypertrophy. The chest x-ray reveals a dilated left
ventricle.
The echocardiogram usually shows a dilated left ventricle with shuddering of the anterior mitral leaflet because of the regorgitant jet
but is generally not helpful in assessing severity.
If the mitral valve closes prematurely because of
very high left ventricular end diastolic pressure
then this is a sign of severe aortic regurgitation;
however, clinically there is little difficulty in establishing severity at that point. One study suggests that if the end systolic dimension is
greater than 5.5 cm 1 then the incidence of subsequent complications is high and surgery may
be indicated . These data have not yet been fully
substantiated, and concomitant coronary disease or a myopathic process limits the value of
this one finding .
Cardiac catheterization will yield information regarding hemodynamics and the degree
of regurgitation.
The symptomatic patient is usually helped
by valve replacement, but the decision to operate in an asymptomatic , or minimally symptomatic , patient with clinically severe regurgitation

is a difficult one. Ideally one would want a battery of noninvasive predictors such as an electrocardiogram, a chest x-ray, and an echocardiogram to predict the subsequent course
and therefore to select the ideal time for surgery. Hirshfeld 8 could establish no relationship
between postoperative improvement or survival
and preoperative heart size by x-ray, ECG, or
New York Heart Association functional class.
Spagnuolo 9 found that in young persons with
rheumatic aortic regurgitation 65% developed
angina, heart failure , or died within three years if
they had the combination of 1) diastolic pressure of less than 40 , 2) cardiomegaly, and 3)
left ventricular hypertrophy on electrocardiogram. With this triad of findings aortic valve
replacement has been suggested.
Another consideration as to valve replacement for aortic regurgitation is that of preservation of myocardial function as in severe pro1on g ed aortic regurgitation ; irreversible
myocardial changes may occur which cannot
be corrected by surgery. The regurgitant volume will be eliminated by surgery and thus the
patient may have symptomatic improvement,
but myocardial function will remain poor; in addition the long-term survival rate with depressed
left ventricular function is worse .8 In the future
one would hope to replace valves at the point
just prior to irreversible myocardial changes, but
at present no tests are available to assess early
irreversible c hanges accurately. Currently, exercise nuclear gated scans are being evaluated
for exercise-induced wall motion abnormalities
which may indicate early irreversible changes 10 ;
the future of aortic regurgitation evaluation lies
in assessing left ventricular function for timely
valve replacement.
In summary , valve replacement is indicated for both symptomatic aortic stenosis
and insufficiency. The prognostically important
symptoms associated with aortic stenosis are
angina, syncope or presyncope , or presyncope
and congestive heart failure. The asymptomatic
patient with aortic stenosis may be considered
for valve replacement , but the long-term advantages of surgery in this group are not clear for
adults. The symptomatic patient with severe
aortic regurgitation is also a surgical candidate.
The asymptomatic patient with clinically severe
aortic insufficiency who has, or subsequently
develops, left ventricular hypertrophy on elec-

trocardiogram , with cardiomegaly and low diastolic blood pressure, may also be considered for
valve replacement; however, the indications are
not as clear-cut as with the symptomatic patient. In the future more emphasis may be
placed on left ventricular function to determine
early irreversible changes so that ventricular
function may be preserved postoperatively . Arguments favoring earlier valve replacement are
decreasing perioperative mortality, modification
in prosthesis design to reduce long term complications, and higher perioperative mortality in the
severely ill patients. The major argument
against earlier valve replacement is that there is
not yet an ideal valve; thus the potential for such
complications as endocarditis, thromboembolism, and valve malfunction still exists.
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Recent Techniques in Echocardiography:
Two-Dimensional Echocardiography
KIRAN B. SAGAR, M.D.
Assistant Professor of Medicine, Division of Cardiology, and Director of Echocardiography, Medical
College of Virginia, Health Sciences Division of Virginia Commonwealth University, Richmond, Virginia

Conventional M-mode echocardiography
is a widely used noninvasive diagnostic technique. It allows bedside assessment of cardiac
chamber dimensions, valve motion and left ventricular function . The limitations of this technique are that it (1) provides only a one-dimensional (icepick) view of the heart, (2) displays
cardiac structures in an unfamiliar form that
bears no resemblance to cardiac anatomy, and
(3) does not provide information regarding spatial orientation of cardiac structures.
These limitations led to the development
of two-dimensional (2-D) real-time echocardiography in the last decade.,_4 The 2-D
echo allows simultaneous visualization of cardiac structures in real time through multiple
planes.
There are two types of commonly used 2D echocardiography:
1 . Mechanical sector scanner. A single
crystal transducer is mounted on a motor
and oscillates in an arc of 30° .2 It is less
expensive than the phased array scanner
and can be interphased with the existent
M-mode echocardiograph . The disadvantages are noisiness, vibrations which the
patient feels on the chest, and a narrow
angle image. Newer, wide-angle mechanical sector scanners will overcome the las'
problem.
2. Phased array wide-angle sector scanner. This technique requires multiple eleCorrespondence and reprint requests to Dr. Kiran B.
Sagar, Box 51, Medical College of Virginia, Richmond , VA
23298 .
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ments in the transducer and there is a series of delays in the firing of the individual
elements so that the ultrasonic wave front
is at an angle to the transducer. By controlling the time sequence, the beam is
electronically swept through a wide-angle
sector. 4
The patient is examined lying supine or in
the left lateral position with head slightly elevated. The echo information is recorded on a
video cassette which can be stored and replayed later. The figures shown here are still
frames of the cine.
The cardiac imaging is done in the following multiple views:
1 . Parasternal long axis. The ultrasonic beam
is parallel to the long axis of the left ventricle.
Figure 1 is the anatomic section of the heart obtained in a presumed long axis plane of the left
ventricle. Figure 2 shows the same structures
seen with the 2-D echo. This view allows evaluation of pathology of the .aortic root, aortic
valve, mitral valve, and left ventricle.
2 . Parasternal short axis. This view is obtained
by rotating the transducer through 90 ° and provides tomographic sections of the heart from
the apex of the left ventricle to the aortic root.
Figures 3 and 4 show the anatomical and 2-D
echo sections at the level of the papillary muscles; Figure 5 shows the 2-D echo sections at
the level of the mitral valve. At this level the mitral valve area can be estimated by measuring
the valve orifice with a planimeter during diastole. Figures 6 and 7 show anatomic sections
and a still frame of a tomographic section of the
sector scan at the level of the aortic valve.

RIGHT VENTRICLE
RIGHT CORONARY

CUSP
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"t..EFT VENTRICULAR
OUTFLOW TRACT
ANTERIOR MJTRAL
LEAFLET
LEFT ATRIUM

POSTERtOR MlTRAL
LEAFLET
POSTEROMEDIAL PAPILLARY
MUSCLE
Fig 1-Anatomic section of heart obtained in presumed plane of long axis of left ventricle.

3 . Apical four-chamber view. This view is obtained by positioning the transducer over the
point of maximal cardiac impulse with the patient in the left lateral position . The ventricles are
at the top and the atria at the bottom. Figures 8
and 9 are the diagrammatic and 2-D echo sections of this view.
4. Suprasternal view. The transducer is in the
suprasternal notch and the ultrasonic beam im-

Fig 2-Long axis view of left ventricle with 2-D echo in a
normal subject. Head of subject towards right, feet towards
left, chest wall at the top, and spine at bottom of figure. Anterior · (AL) and posterior (PL) leaflets of mitral valve and
posteromedial papillary muscle (PM) are seen . RV = right
ventricle, LV = left ventricle, VS = ventricular septum, PW
= posterior left ventricular wall, LA= left atrium, AV= aortic valve.
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Fig 3-Anatomical section of heart along plane of ultrasonic tomographic section at level of papillary muscles.
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Fig 4-Ultrasonic tomographic section of left ventricle at
the level of papillary muscles (PM). Papillary muscles are
seen at approximately 3 and 8 o'clock positions. RV= right
ventricle, LV = left ventricle, VS = ventricular septum, PW
= posterior left ventricular wall, LA = left atrium, AV = aortic valve.

Fig 5-Still frame of sector scan of short axis tomographic
section of left ventricle at the level of mitral valve . In this figure, right ventricle is anterior and to the left. Left ventricle
appears circular and is to the right. Anterior and posterior
mitral leaflets have a fish mouth appearance during diastole . RV = right ventricle, LV = left ventricle, VS = ventricular septum, PW = posterior left ventricular wall, LA =
left atrium , AV= aortic valve.

MON CORONARY

Sf NUS
Fig 6-Anatomic section of heart obtained along presumed ultrasonic tomographic section at level of aortic valve .
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ages the ascending aorta. This view is useful for
the diagnosis of coarctation of the aorta.5

Contrast Echocardiography
Contrast echocardiography is of value in
detecting right-to-left shunt and tricuspid regurgitation. The usual contrast medium is a mixture
of 5 ml of normal saline and 2 ml of air which
are shaken together in a syringe to form microcavities then injected into a peripheral vein . An
important precaution is to avoid injecting visible
air bubbles. Two ml of green dye produce similar results. Figure 1 0 shows opacification of the
right atrium, right ventricle, and pulmonary artery, following an injection of normal saline in a
tomographic section at the level of the aortic
valve .
Fig 7---Still frame of a tomographic section at level of aortic
valve. Aorta appears circular. Three leaflets of aortic valve
during diastole form a Y (R = right, L = left, N = noncoronary). Left atrial cavity is directly posterior to aortic root
and left atrial appendage (LAA) is towards right of figure.
Right atrium (RA) and tricuspid valve (TV) are on left of figure. Right ventricular outflow (RVO) tract, pulmonic valve
(PV), and main pulmonary artery (MPA) are on top of figure.
Atrial septum (AS) is also seen.

Clinical Application of 2-D
Echocardiography
The 2-D echo is still in the developmental
phase and further investigations are required to
establish its accuracy, sensitivity, and specificity. However, it has already made a significant
contribution in the assessment of the severity of

Fig 8-Left. Demonstration of placement of the transducer over apex and plane of tomogram. The image is displayed as if one
were looking from below in the position of left hip, showing right and left atria (RA and LA) and right and left ventricles (RV and
LV). Right. Section of the normal heart shown as it appears on the picture at left cardiac apex at top. RA = right atrium, LA
= left atrium, RV= right ventricle, LV = left ventricle.
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BASE
Fig 9---Diagrammatic representation (left) of apical image (right) . The right ventricle (RV) shows coarse trabeculation whereas
the left ventricle (LV) is smooth. The tricuspid and mitral valves (TV and MV) are seen . The ventricular septum is seen between
the two ventricles. The interatrial septum is seen between right and left atria (RA and LA).

mitral and aortic stenosis, regional and global
abnormalities of the left ventricular wall motion,
and congenital heart diseases.

Mitral Stenosis
Quantitative assessment of the mitral
valve area with 2-0 echo shows excellent correlation with the mitral valve area obtained by cardiac catheterization (r = 0 .95}6 and at operation (r = 0.92). 7

Mitral Valve Prolapse and Flail Mitral Valve
Two-dimensional echocardiography has
accurately defined patterns of mitral valve prolapse and flail mitral valve due to ruptured
chordae tendinae. 8
Aortic Stenosis
Two-dimensional echocardiography not
only localizes the level of aortic obstruction, that
is, valvular, subvalvular or supravalvular9 but
also allows noninvasive separation of significant
from insignificant aortic stenosis. In our laboratory, patients with an aortic valve dia'meter of
<1 .3 cm (obtained in the long axis) and concentric left ventricular hypertrophy had a mean
aortic gradient of >50 mm Hg at cardiac catheterization . 1 0
Left Ventricular Wall Motion
Regional and global left ventricular wall
motion abnormalities can be studied noninvasively. The 2-D echo provides an ultrasonic
angiogram of the left ventricle and thus left ventricular volumes and ejection fraction can be estimated. At the present time we still need validation of the accuracies and inaccuracies of the
technique.

Fig 10- Tomographic section at the level of aorta, after intravenous injection of normal saline. Note opacification of
right atrium (RA) and right ventricular outflow (RVO) tract.
Pulmonic valve (PV), aorta (AO), and left atrium (LA) are also
seen.
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Coronary Artery Disease
There are reports of detection of left main
coronary artery lesions with 2-D echo-

cardiography . 11 Further investigations are
needed to define sensitivity and specificity of
this technique.

Congenital Heart Disease
Two-dimensional echocardiography
should prove helpful in delineating cardiac anatomy in critically ill infants who are at a high risk
tor cardiac catherization as well as aid in the diagnosis of lesions such as atrial septal defects,
ventricular septal defects, A-V canal defects,
and transposition of great vessels.
In conclusion, the development of 2-D
wide-angle echocardiography is a hallmark in
the use of ultrasound as a diagnostic tool. It allows simultaneous visualization of cardiac structures in real time through multiple planes without known risk to the patient.
Figures 1 , 2, 3 ,4, 5, 6, 7, and 1 0 are reproduced by
permission from Mayo Clinic Proceedings (53:271-303,
1978).
Figures 8 and 9 are reproduced from Circulation
(57:503-511, 1978) by permission of the American Heart
Association, Inc.
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Management of the Difficult Hypertensive
Patient
A. JARRELL RAPER, M.D.
Associate Professor of Medicine, and Director, Outpatient Cardiology Services, Medical College of
Virginia, Health Sciences Division of Virginia Commonwealth University, Richmond, Virginia

Hypertension, while usually easily handled , can in certain patients present difficult
problems in management.

Previous Neurological Disease
A history of stroke sometimes creates
doubt as to the advisability of lowering the blood
pressure as this might reduce flow to the brain ,
causing the patient to have another stroke. It is
recognized that severe hypertensives clearly do
better if they are treated,' ·2 but the mild-to-modera te hypertensive patient with a history of
stroke is a more difficult problem , and uncertainty about proper management has been so
great that a large multicenter clinical trial-random i zed, double-blind , and placebo-controlled-of 452 patients was done by the
Stroke-Hypertensive Study group , and its results
reported in 1974. 3 All 452 patients had a history of a previous stroke and all had mild-tomoderate diastolic hypertension . This study
showed that long-term outpatient treatment of
the blood pressure neither caused nor prevented a second stroke. Other benefits such as
a reduction in the number of episodes of congestive heart failure were evident in the treated
group. It would seem, then, that patients with a
history of stroke should be treated for their diastolic hypertension, unless there are other contraindications.

Correspondence and reprint requests to Dr. A. Jarrell
Raper , Box 1 05, Medical College of Virginia, Ri chmond , VA
23298.

64 /

MCV OUARTERL Y 15(2):64-67, 1979

Isolated Systolic Hypertension
Another difficult problem is that of "isolated systolic hypertension ," that is , blood pressure of 1 80 / 7 4 mm Hg , a condition common
among older people.
Data from the Framingham study have
shown that the age-corrected morbidity ratio is
correlated with systolic or diastolic hypertension
or both ,4 as it is for stroke, congestive heart failure, and renal disease. Increased systolic blood
pressure is therefore clearly a risk factor for cardiovascular damage, and one might assume
that it ought to be lowered. Of the large, carefully conducted blood pressure treatment trials
that show patient benefit (decreased death or
morbidity) , all required that patients have diastolic hypertension to get into the study and did
not include those with such pressures as 180 I
7 4 mm Hg; these might have a stiff aorta and
great vessels, requiring a high systolic pressure
to pump a given stroke volume into the vascular
system . In addition, treatment of the patient's
180 mm Hg systolic pressure will also lower the
diastolic pressure, which may be undesirable.
Symptomless coronary heart disease does exist, and blood flow through the coronary arteries
is, of course, heavily dependent upon diastolic
pressure, even more so in the presence of diseased arteries.
When encountering a patient with a wide
pulse pressure or with a severe systolic hypertension and normal diastolic pressure , one
should look for aortic insufficiency. Severe
anemia , arteriovenous fistula, or thyrotox!cosis
can also produce systolic hypertension.
Once these conditions are ruled out, the

decision to treat or not to treat must be faced.
Unfortunately, there are no data to indicate that
such patients can be helped by treating their
isolated systolic hypertension. In the face of this
uncertainty, treatment is recommended only
when the patient has clear evidence of definite
cardiovascular damage that appears to be due
to the hypertension per se ; definite left ventricular hypertrophy might be present, for example,
with no other explanation.
The systolic blood pressure usually rises
with age in the American population 5 which puts
some millions of primarily elderly people at risk
for untreated hypertension or at risk for treatment-induced complications. This is an important clinical problem that has not yet had the
systematic and careful study which it deserves.
i

Mild Diastolic Hypertension
.Whether or not to treat mild diastolic high
blood pressure (96 mm Hg) may also cause uncertainty, but the Veterans Administration Cooperative Study Group, interpreted by Doctor
Freis, has helped to clarify this question. 6 If the
diastc)lic blood pressure is high enough (over
1 04 mm Hg), one should go ahead and treat on
the basis of the blood pressure alone . At lower
levels, the presence of "risk factors" for hypertensi\le damage should be sought. These include the usual risk factors for atherosclerosis,
such as hypercholesterolemia, diabetes, family
history, obesity, among others, and age (youth),
and race (black). If several risk factors for hypertensive damage are present, or if cardiovascular
damage itself is already evident, one should
treat the patient with borderline hypertension.
Lack of Response to Therapy
Occasionally, a patient may not respond
to the prescribed medication . One reason for
this might be incorrect cuff size. In dealing with
an obese patient, this can be an important factor, causing as much as 1 O mm Hg diastolic
error, or more. Current recommendations of the
American Heart Association are for a cuff (bladder) width "25% greater than the diameter of
the arm"; thus , the standard cuff bladder, 1 2 x
22 cm, is suitable for a 1 0 cm (4-inch) diameter
arm.
Other reasons why the patient may not be
responding to treatment could involve technical
factors. For instance, if the patient is engaged in
conversation while the pressure is being taken ,

the diastolic blood pressure rises slightly. A cold
room also raises the blood pressure, systolic
and diastolic, as does recent cigarette smoking
or an office "climate" that is rushed and hurried . A number of referrals have turned out to be
patients who are able to recall that the office atmosphere in which their blood pressure was
previously taken was hectic, or that they themselves were very rushed and hurried.
Another reason for non-response is that
the patient may not be taking his or her medication. An estimated 25% to 50% of patients (depending upon definitions used) will be "noncompliant.' ' Sometimes these individuals return
regularly to see their doctor, even though they
are not taking their medication; they may even
count out the appropriate number of pills and
throw them in the trash, so that the number remaining in the bottle appears to be correct to
the physician. The best weapon against this is a
good doctor-patient relationship in which the
patient is assured of the physician's interest.
For example , it helps to ask the patient if he or
she is taking the prescribed medication regularly. If the answer is yes and the patient seems
to be certain about it, the physician should inquire if the medication was taken on schedule
that day and the night before . If the patient appears at all uncertain, the physician can then
describe the difficulty created by not following
treatment , and how this can inadvertently cause
over-treatment. Patient education as to the nature of the disease and how complications are
avoided has been carefully studied as a means
to help compliance, but it has not been as successful as had been hoped.
Simplicity of treatment is very important .
Most antihypertensive medications need only be
taken twice a day at most. Drug combinations
may help if the right combination can be found
to fit the patient's needs.
A patient may be complying with prescribed medication and yet still not respond to
treatment . The most common cause for this is
subtle fluid retention . The body can retain anywhere from 5 to 11 pounds (depending on body
size) of extra fluid without producing obvious
edema that can be detected on physical examination; thus , a severe hypertensive should be
weighed on every office visit. The extra fluid can
be eliminated by salt restriction or by more powerful diuretics; this will often restore the responsiveness of the patient to the same program of
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antihypertensive medication . Frank congestive
heart failure also interferes with the response to
medications, as does deteriorating renal function, when blood pressure medicines can become ineffective.

Malignant (Accelerated) Phase of Hypertension
Non-response to treatment may be
caused by the fact that the patient is entering
the malignant phase of hypertension; high diastolic pressures (130 mm Hg) will be present .
This is, of course, a body-wide problem; the
basic lesion, fibrinoid necrosis, occurs in arterioles all over the body. The condition can be
diagnosed in the office by the following clinical
manifestations:
1 . Acute hypertensive retinitis or retinopathy: flame-shaped hemorrhages,
and fluffy exudates , perhaps with papilledema.
2 . Hypertensive encephalopathy: diffuse
cerebral dysfunction, perhaps with
somnolence , coma, and/or convulsions.
3 . Malignant nephrosclerosis: microscopic
or gross hematuria and proteinuria
These manifestations are totally curable
by lowering the blood pressure to normal, unless the renal lesion has progressed far enough
to produce gross decrease in renal function, at
which point renal damage may be arrested or
slowed , but not cured.
Once malignant hypertension has been
halted , the prognosis is still poor. However, as
long as the blood pressure is kept down , this
syndrome will not return. Patients with newlydiscovered malignant hypertension should be
hospitalized for immediate control of the blood
pressure.
Secondary Hypertension
Trouble may occur with pressure control
when the patient has an unrecognized cause of
high blood pressure. Pheochromocytoma is a
classic example and these patients have notoriously erratic blood pressure that is very difficult
to control . Coarctation of the aorta can cause
real trouble as very satisfactory blood pressure
levels may be produced below the coarctation
and yet be uncontrollable above the coarctation. Perhaps the patient is on birth-control hormones which in some cases can cause pro66 /
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nounced hypertension. The possible use of
artificial female hormones should be ascertained in women of childbearing age or even
post-childbearing years.

Severe Hypertension
Severe hypertension can be difficult to
manage . Hemodynamic studies have shown
that these patients have normal cardiac output,
normal heart rate, normal stroke volume, and
normal cerebral blood flow unless they are in
heart failure or severe renal failure. Subtle alterations in blood flow to several other parts of the
body occur and renal blood flow is usually reduced. The small arterioles, because of their
size, offer extremely high resistance to blood
flow throughout the body . Treatment should begin with a diuretic, not because there will be an
adequate response to the diuretic alone but because it decreases the amount of other medications that are required, and is therefore a reasonable foundation for therapy.
Hydrochlorothiazide is usually used, 50
mg twice a day, unless fluid retention is a problem, in which case furosemide is used; a lowsalt diet can help, as can weight loss if the patient is grossly obese . It is extremely difficult to
get a grossly obese patient to lose weight, but
when successful, the weight loss will lower the
blood pressure to a surprising degree.
Of course, other medications are going to
be needed in addition to the thiazide. Methyldopa or propranolol could be added . Methyldopa is marketed as Aldomet. The highest dose
that does any good in a large patient is a total of
about 3. 5 gm a day divided into two doses.
Beyond that, little, if any , blood pressure
change occurs and there is the possibility of an
increase in toxicity.
Propranolol is marketed as lnderal and is
a beta-receptor blocker . It affects not just the
cardiovascular system but also blocks beta-receptors in the lungs and receptors in the endocrine system, so that there is the possibility of
worsening of the asthmatic patient, or leaving
the labile diabetic patient defenseless against
hypoglycemia. It has recently been found that
larger doses of propranolol are useful, and European and Australian physicians are using up
to 1 gm per day if the patient needs it and can
tolerate it well .7 We have not given quite this
much at the Medical College of Virginia , but we
are gradually moving to higher doses. Exactly

why propranolol has a good effect on the blood
pressure in these high-dosage ranges (beyond
what seems to do any good for angina pectoris)
is something of a mystery. Propranolol is better
tolerated in some ways than guanethidine, and
causes less orthostatic hypotension.
Guanethidine is a useful and powerful
antihypertensive but causes orthostatic hypotension, as well as intestinal and sexual problems. The dose is extremely variable, and must
be individually adjusted, but nearly all hypertensive patients respond favorably to this drug . The
problem is that it can produce intolerable side
effects. Guanethidine and phenoxybenzamine
given together have been shown to be useful in
a few patients who do not respond to guanethidine and a diuretic alone.
A new beta-blocker has been recently
marketed-metoprolol (Lopressor) . It is promoted as being less toxic to the pulmonary and
endocrine systems. There is evidence that it is
especially useful in patients with obstructive
lung disease, although it is not completely devoid of action on pulmonary beta receptors.
If a patient is unresponsive to thiazide plus
propranolol or guanethidine, a vasodilator may
be added. Hydralazine is an excellent vasodilator and would be even more powerful if we
could give enough . Long-term treatment must
be limited to about 200 mg a day for an average-size patient because of a lupus-like syndrome that occurs at higher doses with disturbing frequency. I do not know of a single
convincing case of lupus-like syndrome at MCV
caused by less than 200 mg of hydralazine,
and I have been looking specifically for it for the
last twelve years.
Prazosin (Minipres) has been recently
marketed as a vasodilator. There is some evidence that it has an additional alpha-blockade
effect, but the exact balance between these two
actions is not well known . It is useful up to 20
mg a day.

If all these drugs have been tried and the
hypertension is still uncontrolled, hospitalization
is indicated. At this time the physician can determine if any further action is required , such as
an arteriogram , to eliminate the possibility of
renal artery stenosis if the patient seems to be
otherwise a reasonable surgical candidate for
its correction . Hospitalization also presents an
opportunity to look for other causes of hypertension that might be corrected. Under these
conditions, it is always possible to control the
blood pressure somehow, using parenteral
medications. Later, the patient can be taken off
parenteral medication and put on oral agents.
The patient will usually be more responsive to
the drugs, at least for a while, after hospitalization .
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Hyperuricemic Nephropathy: A
Complication of Acute Leukemia in Children
JAMES C. M. CHAN, M.D.
Professor and Director, Nephrology Section, Department of Pediatrics, Medical College of Virginia,
Health Sciences Division of Virginia Commonwealth University, Richmond, Virginia

Introduction
In order to provide a point of reference for
a rational approach to the therapy of acute uricemic nephropathy, the metabolic pathways
leading to the production of uric acid will be
I
briefly reviewed .
Uric acid is the end-product of adenine
and guanine metabolism. Relevant to this discussion is the xanthine oxidase enzyme which
catalyzes the conversion of hypoxanthine to
xanthine and xanthine to uric acid. In children
with acute leukemia the increasing production
and subsequent destruction of white blood cells
result in the rapid elevation of uric acid concentration in the plasma, especially during treatment with antineoplastic drugs. This in turn may
lead to the development of acute hyperuricemic
nephropathy. 1 - 4
The uric acid deposition in the renal medulla causes obstructive uropathies. This occurrence is not uncommon in children treated for
reticuloendothelial malignancies, sarcoma and
acute lymphocytic leukemia.
Incidence
The work done at the National Cancer Institute of the National Institutes of Health (NIH)
Correspondence and reprint requests to Dr. James
C. M. Chan, Box 822 , Medical College of Virginia, Richmond, VA 23298.
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showed that 6 out of 5 7 patients with acute leukemia developed uric acid nephropathy. 4 The
treatment had consisted of methotrexate, 6mercaptopurine, hydrocortisone and cortisone.
The duration of treatment before the clinical onset of hyperuricemic nephropathy was from
three to six days. The maximum elevation of
white cells was 11,800 to 18,000 per mm 3 ; of
uric acid from 1 7 to 71 ; and of BUN from 51 to
212 mg/1 OOml.
A number of subsequent reports have amply confirmed and extended these observations
of Frei et al, 4 and a number of conclusions can
be made.

Risk Factors
Uric acid nephropathy is more prone to
develop in the treatment of acute lymphocytic
leukemia when the following conditions are
present: elevation of white blood cells to more
than 20,000 / mm 3 , marked adenopathy, especially in the mediastinum, and massive hepatosplenomegaly.
The histology of severe uric acid nephropathy includes intratubular hydronephrosis and
infarction from uric acid obstruction 5 · 6 ; the
milder and more common form of uric acid nephropathy shows marked renal enlargement
produced by the intense interstitial leukemic infiltration; the glomeruli and tubules are intact.
There is a good correlation between the kidney

and liver size in patients with less than 5% leukemic infiltration of these organs. 4

leLJcocytosis, leucopenia and, rarely, peripheral
neuritis and bone marrow depression .

Treatment
The first two modes of treatment rely on
the provisions of a more favorable situation for
the deposition of uric acid which is reduced
when the urinary pH is made alkaline in excess
of 6, beyond which point the solubility of uric
acid is increased in an exponential fashion .
To insure a good urine output , intravenous
5% dextrose/water is administered at a rate of
3000 ml/m 2 /day. To promote uric acid solubility and therefore enhance excretion, the urine
may be made alkaline by administering intravenous sodium bicarbonate at a dosage calculated to elevate the serum bicarbonate by 1 0
mEq/liter, and/or the use of a carbonic anhydrase inhibitor acetazolamide to block the renal
tubular reabsorption of bicarbonate. The aims
of these general measures are to achieve a urinary pH in excess of 6 and a urine volume in excess of 60 ml/m 2 /hour.
If the urine output is less than 60 ml/m 2 /
hour after rehydration, mannitol (25% aqueous
solution) is given initially over a 5- to 1 0-minute
period in a test dose of 6 .25 gm in children
weighing less than 30 kg and 12 .5 gm in children weighing over 30 kg . If diuresis ensues,
additional mannitol is administered in the same
dose every 6 hours to achieve a urine output of
at least 60 ml/m 2 /hour.
It is important to obtain and record urine
volume, pH, body weight, vital signs, blood uric
acid, electrolytes , BUN, and calcium concentrations every 1 2 to 24 hours.
Normal glomerular filtration rates are
achieved within 2 to 1 4 days of treatment of hyperuricemia with fluids , bicarbonate and acetazolamide. 7

Special Therapy
The rapid removal of uric acid can be
achieved by either peritoneal dialysis or hemodialysis.
Peritoneal dialysis removes uric acid at a
rate of 1 5 ml / min, but hemodialysis is at least
five times more effective . 1 · 2 The decision on
when to institute these procedures is a clinical
one and is based on the physician 's past experience and the patient's status . One example of
this complex clinical decision is shown in the
Figure .

Allopurinol
Allopurinol (1 0 mg/kg/day initial oral
dose) is a useful drug for the treatment of hyperuricemia. 7 · 8 Allopurinol is a potent inhibitor of
xanthine oxidase for which it is also a substrate .
Although the incidence of side effects is
very low, the potential complications of allopurinol treatment should always be kept in mind .
These include skin and blood dyscrasias, malaise, fever, complaints of nausea, headache,
vomiting, vertigo, drowsiness and gastric irritation, muscle ache, elevation of SGOT /SGPT,
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Figure--Acute uric acid nephropathy and treatment with
hemodialysis is illustrated in the clinical course of a 1 4-yearold white boy.
Acute uric acid nephropathy occurred at the time
of leukemic relapse. Diuresis did not occur despite
all the general treatment procedures. Peritoneal
dialysis was only partially successful in the removal of 4 gm of uric acid in 24 hours without
lowering the serum uric acid concentration. Hemo
dialysis was instituted and removed over 1 7 gm of
uric acid resulting in a decrease of serum uric acid
from 87 to 29 mg/di. Immediately following dialysis, he was given 25 gm of intravenous mannitol
and was started on allopurinol. However, anuria
persisted and a second course of hemodialysis
was performed for 6 hours, resulting in a decrease
of serum uric acid from 46 to 19 mg/di. Just before the completion of the dialysis, he voided 340
ml of urine and the output remained adequate
thereafter aided by good fluid and conservative
medical management.
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The use of hemodialysis is dependent on
machine availability and the existence of a specially trained nephrology team consisting of
dialysis technicians, nurses, surgeons, and
nephrologists. Peritoneal dialysis requires less
technical hardware and can be initiated more
promptly by the nephrologist; whereas, before
hemodialysis can be initiated, vascular access
and somewhat extensive preparations are
needed, especially in small children in the 2- to
3-year age group, where uric acid nephropathy
more commonly occurs.
There is a relationship between the days
of oliguria before dialysis has been started and
the number of days until diuresis begins 2 which
has been taken as an indication for the early institution of either of these special procedures
within a day or two of anuria and/or rapidly rising serum uric acid concentrations.

Summary
Hyperuricemic acute nephropathy occurs
in 1 0% of patients with leukemia; the intrarenal
uric acid deposition results in obstructive uropathy.
The clinical findings which point to the
likelihood of renal damage are: first, an initial
white blood cell count in excess of 20,000 /
mm 3 ; second, marked adenopathy especially in
the mediastinum; and third, the presence of
massive hepatosplenomegaly. The aim of general treatment with fluids and renal alkalinization
is to promote uric acid solubility and output by
maintaining urine pH in excess of 6 and urine
volume in excess of 60 ml / m 2 / hr. The discovery and clinical use of allopurinol, an analogue
of hypoxanthine and an inhibitor as well as a
substrate of the enzyme xanthine oxidase, is
central to the control of hyperuricemia. Allopurinol , as well as its metabolic end-product, alloxanthine, acts at the terminal steps of uric acid
metabolism to reduce the production of uric
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acid and in conjunction with the other general
medical therapy, contributes to the reversal of
the hyperuricemia.
Finally, the special extrarenal procedures
of peritoneal dialysis and hemodialysis can rapidly, efficiently and safely remove the uric acid
from the body. The sooner one initiates either of
these procedures, the earlier diuresis begins.
Acknowledgment: The author thanks Mrs.
Linda Watson for expert secretarial assistance.
The Figure is reproduced with permission from Journal of Pediatrics(7 2:358 -366, 1968)
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